HIGHLIGHTS
- who: Zhidong Liu from the The study is designed as a multicentre, randomized, double-blind, placebo-controlled, parallel design clinical trial in which subjects were randomly assigned in a, :, ratio to either an intervention (DDG combined with metformin) or a control group (placebo combined with metformin)The random number assignment will be provided by the Clinical Research Center of Longhua Hospital Affiliated to Shanghai University of Chinese Medicine. Participants in each group will receive , weeks of treatment and follow-up for , weeks after treatment. The study flow chart is shown in Fig., . We will record all baseline . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.